| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |